{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:12:11Z","timestamp":1787983931977,"version":"build-2784847793"},"reference-count":17,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2019,4,1]]},"abstract":"<jats:p>\n                    Allergic contact dermatitis (ACD) has been traditionally identified as T\n                    <jats:sub>H<\/jats:sub>\n                    1-mediated delayed-type hypersensitivity reactions. There is currently no Food and Drug Administration\u2013approved systemic therapy indicated for ACD. Among patients with ACD, there is a subgroup that experience not only concomitant atopic dermatitis and ACD but also systemic allergic dermatitis driven by allergens encountered through dietary consumption. Basic science and clinical studies have supported the notion that ACD involves a complex interaction between both T\n                    <jats:sub>H<\/jats:sub>\n                    1 and T\n                    <jats:sub>H<\/jats:sub>\n                    2 axes of the secondary immune system on an allergen-by-allergen basis. Herein, we report the patients with systemic allergy syndrome with dermatitis to either Balsam of Peru or nickel who achieved remarkable improvement and regained their quality of life without continuing adherence to strict diets. Our study suggests that dupilumab may be an efficacious solution for a particular subgroup of patients with recalcitrant ACD when first- and second-line therapies have failed.\n                  <\/jats:p>","DOI":"10.1097\/der.0000000000000446","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T16:54:54Z","timestamp":1551804894000},"page":"164-167","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":26,"title":["Dupilumab for Systemic Allergy Syndrome With Dermatitis"],"prefix":"10.1177","volume":"30","author":[{"given":"Sharon E.","family":"Jacob","sequence":"first","affiliation":[{"name":"From the, *Department of Dermatology, Loma Linda University, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin T.","family":"Sung","sequence":"additional","affiliation":[{"name":"School of Medicine, University of California, Riverside; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Machler","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, New York University, New York City."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0378-6323.25633","article-title":"Systemic contact dermatitis","volume":"72","author":"Bajaj AK","year":"2006","unstructured":"Bajaj AK, , Saraswat A. Systemic contact dermatitis. Indian J Dermatol Venereol Leprol, 2006; 72:99\u2013102.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_3_1_3_2","first-page":"763","article-title":"Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects","volume":"69","author":"Peiser M","year":"2012","unstructured":"Peiser M, , Tralau T, , Heidler J, et al. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci, 2012; 69:763\u2013781.","journal-title":"Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci"},{"key":"e_1_3_1_4_2","unstructured":"DUPIXENT (dupilumab) injection - 761055lbl.pdf. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761055lbl.pdf. Accessed March1 2018."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2007.02719.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1523-1747.1999.00550.x","article-title":"Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice","volume":"112","author":"Traidl C","year":"1999","unstructured":"Traidl C, , Jugert F, , Krieg T, et al. Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol, 1999; 112:476\u2013482.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05634.x"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.010"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.183.3.1001","article-title":"T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4\/Il-10-producing (Th2) negative regulatory CD4+ T cells","volume":"183","author":"Xu H","year":"1996","unstructured":"Xu H, , DiIulio NA, , Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4\/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med, 1996; 183:1001\u20131012.","journal-title":"J Exp Med"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2013.11.008"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2009.05.005"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114738"},{"key":"e_1_3_1_13_2","first-page":"754","article-title":"Dietetic interventions in allergic contact dermatitis\u2014when are they reasonable? [in Polish]","volume":"72","author":"Spiewak R","year":"2015","unstructured":"Spiewak R. Dietetic interventions in allergic contact dermatitis\u2014when are they reasonable? [in Polish]. Przegl Lek, 2015; 72:754\u2013758.","journal-title":"Przegl Lek"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mjd.2001.117734","article-title":"Surviving on a balsam-restricted diet: cruel and unusual punishment or medically necessary therapy?","volume":"45","author":"Belsito DV","year":"2001","unstructured":"Belsito DV. Surviving on a balsam-restricted diet: cruel and unusual punishment or medically necessary therapy?. J Am Acad Dermatol, 2001; 45:470\u2013472.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e31828afab2"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.043"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000409"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"e12701","DOI":"10.1111\/dth.12701","article-title":"A case series of dupilumab-treated allergic contact dermatitis patients","volume":"31","author":"Goldminz AM","year":"2018","unstructured":"Goldminz AM, , Scheinman PL. A case series of dupilumab-treated allergic contact dermatitis patients. Dermatol Ther, 2018; 31:e12701.","journal-title":"Dermatol Ther"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000446","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:04:46Z","timestamp":1777399486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,1]]}},"alternative-id":["10.1097\/DER.0000000000000446"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000446","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}